New insights into the pathophysiology, classification, and diagnosis of coronary microvascular dysfunction

Bina Ahmed1

  • 1Division of Cardiology, School of Medicine, University of New Mexico, Albuquerque, New Mexico, USA.

Insights

Coronary microvascular dysfunction (CMVD) predicts poor outcomes in heart disease patients. Despite its prevalence, effective targeted therapies for CMVD are lacking, necessitating further research.

Area of Science:

  • Cardiology
  • Vascular Biology
  • Diagnostic Imaging

Background:

  • The coronary microvasculature is crucial for regulating coronary blood flow and myocardial oxygen supply.
  • Coronary microvascular dysfunction (CMVD) is increasingly recognized as an independent predictor of adverse cardiovascular outcomes.
  • Understanding CMVD is challenging due to the complexity of microvascular anatomy and functional pathways.

Purpose of the Study:

  • To review the current understanding of coronary microvascular dysfunction (CMVD).
  • To discuss the diagnostic challenges and limitations of current assessment tools for CMVD.
  • To highlight the clinical significance and unmet therapeutic needs in managing CMVD.

Main Methods:

  • Review of existing literature on coronary microvasculature and CMVD.
  • Discussion of invasive and noninvasive diagnostic modalities for assessing CMVD.
  • Analysis of current clinical classifications and treatment recommendations for CMVD.

Main Results:

  • CMVD is prevalent across various cardiac conditions, with or without epicardial coronary artery disease.
  • Invasive assessment of coronary blood flow and microvascular resistance remains the gold standard.
  • Despite recognized poor outcomes, targeted therapies for CMVD are currently unavailable.

Conclusions:

  • CMVD is a significant clinical entity associated with poor prognosis in cardiovascular disease.
  • Current management focuses on symptom relief and risk factor modification due to a lack of specific therapies.
  • There is a critical need for robust clinical trials to evaluate targeted treatment strategies for CMVD.

Related Concept Videos

Coronary Artery Disease I: Introduction01:30

Coronary Artery Disease I: Introduction

Coronary Artery Disease (CAD): An Overview with Scientific InsightsCoronary Artery Disease (CAD), often referred to as C-A-D, is a prevalent blood vessel disorder classified under the broader category of atherosclerosis. Atherosclerosis is a pathological process characterized by the hardening and narrowing of arteries due to the accumulation of atherosclerotic plaques. These plaques are composed of cholesterol, fatty substances, inflammatory cells, calcium, and fibrin, reducing blood flow to...
Coronary Artery Disease II: Pathophysiology01:26

Coronary Artery Disease II: Pathophysiology

Coronary Artery Disease (CAD) originates from a series of events that impair the function of coronary arteries, the blood vessels responsible for delivering oxygen-rich blood to the heart muscle. The pathophysiology of CAD is closely linked to atherosclerosis, a chronic inflammatory and lipid-driven condition affecting the vascular endothelium.1. Endothelial DamageThe process begins with damage to the vascular endothelium, which serves as a protective barrier between the blood and the vessel...
Coronary Artery Disease III: Clinical Manifestations01:30

Coronary Artery Disease III: Clinical Manifestations

Coronary Artery Disease (CAD) is a primary health risk worldwide, leading to significant morbidity and mortality. The condition arises from the buildup of atherosclerotic plaques within the coronary arteries, resulting in diminished blood supply to the heart muscle.The clinical manifestations of CAD vary widely, from asymptomatic stages to severe, life-threatening conditions. Understanding these manifestations is crucial for early diagnosis and effective management.Angina Pectoris: The Warning...
Acute Coronary Syndrome II: Pathophysiology and Clinical Manifestations01:19

Acute Coronary Syndrome II: Pathophysiology and Clinical Manifestations

The pathophysiology of Acute Coronary Syndrome [ACD] involves several key processes:The main underlying cause of ACD is atherosclerosis, a chronic inflammatory disease characterized by the buildup of lipid-laden plaques within the coronary arteries.As the atherosclerotic plaque grows in the coronary artery, it may become unstable due to the formation of a lipid-rich core and a thin fibrous cap. Inflammatory cells within the plaque, such as macrophages, secrete enzymes that degrade the...
Acute Coronary Syndrome III: Diagnostic Studies01:30

Acute Coronary Syndrome III: Diagnostic Studies

Diagnosing acute coronary syndrome or ACS begins with a thorough patient history. Notable symptoms include central, crushing chest pain radiating to the left arm, neck, jaw, or back, along with shortness of breath, sweating (diaphoresis), nausea, vomiting, dizziness, and palpitations.It is crucial to note any history of cardiac illnesses and assess risk factors, including age, gender, smoking, hypertension, diabetes, hyperlipidemia, and a sedentary lifestyle.During physical examination, vital...
Peripheral Arterial Disease II: Clinical Manifestations and Diagnostic Evaluation01:21

Peripheral Arterial Disease II: Clinical Manifestations and Diagnostic Evaluation

Clinical manifestationsPeripheral Arterial Disease (PAD) manifests through a range of symptoms, from the characteristic intermittent claudication to atypical presentations and severe complications in advanced stages. Intermittent claudication, a hallmark symptom of PAD, presents as exercise-induced muscle pain that typically resolves within minutes of rest. This pain is reproducible and stems from inadequate blood flow, leading to the accumulation of lactic acid produced during anaerobic...